
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Neonatology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1582881
This article is part of the Research Topic Care of the extremely preterm infant View all 8 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To determine whether administering low-dose hydrocortisone early in treatment reduces the risk of bronchopulmonary dysplasia (BPD) in infants born before 26 weeks of gestation Study Design: This retrospective case-control study compared the incidence of Grade II + BPD between infants who received hydrocortisone treatment and those who did not. Propensity score matching was used to ensure comparability between the groups, with a 1:1 match ratio based on gestational age and birth weight.Results: A total of 66 infants were included in the study. Those who received early low-dose hydrocortisone demonstrated a significantly lower risk of Grade II + BPD incidence(p = 0.024).Additionally, early administration of low-dose hydrocortisone was associated with a shorter duration of non-invasive ventilation days (p = 0.038). Multiple logistic regression analysis confirmed that hydrocortisone treatment was independently associated with a reduced risk of Grade II+ BPD incidence (OR: 0.287, 95% CI: 0.084-0.980).These findings suggest that early administration of low-dose hydrocortisone is associated with a reduced risk of Grade II + BPD incidence in extremely preterm infants born before 26 weeks of gestation.
Keywords: Bronchopulmonary Dysplasia, Hydrocortisone, preterm infants, Gestation age, Birth Weight
Received: 25 Feb 2025; Accepted: 01 Apr 2025.
Copyright: © 2025 Yao, Huang, Chen, Yang, Li and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fang Yao, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China
Qiuping Li, Department of Pediatrics, Seventh Medical Center of The Chinese PLA General Hospital, Beijing, China
Bingchun Lin, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.